SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus

Clinical trial NCT06364930 · RECRUITING

Trial details

NCT number: NCT06364930
Sponsor: Chinese University of Hong Kong
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2024-03-26
Primary completion: 2030-10-31
Enrollment: 412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.